McKesson inked a deal to buy a controlling interest in Prism Vision Holdings, as it also logged higher profit and revenue in its fiscal third quarter. The drug distributor said Wednesday that it ...

Based on our third quarter performance, we are raising and narrowing our guidance range for fiscal 2025 Adjusted Earnings per Diluted Share to $32.55 to $32.95. We are also pleased to announce the ...

McKesson posted adjusted earnings per share of $8.03 for the quarter ended December 31, 2024, missing the analyst consensus of $8.27. Revenue came in at $95.29 billion, up 18% YoY but below the $95.77 ...

McKesson Corporation MCK recently announced that it has signed a definitive agreement to acquire a controlling interest in ...

Learn more about whether Equitable Holdings, Inc. or Fidelity National Information Services, Inc. is a better investment ...

McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM ...

Luke Tuttle, who's held roles at industry giants including Experian and Klarna, will lead MoneyGram's product development and ...

McKesson Corporation has signed a definitive agreement to acquire an 80% stake in Prism Vision Holdings from Quad-C for approximately $850 million.

Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...

After the purchase concludes, the firm intends to include PRISM Vision into its U.S. Pharmaceutical division subject to ...

McKesson (NYSE:MCK), a diversified healthcare services company, has announced plans to acquire an 80% stake in PRISM Vision ...